A synthetic small molecule compound called AQAMAN can prevent and even reverse harmful protein build-up in neurons that is associated with several rare neurodegenerative disorders, including polyglutamine (or polyQ) diseases.
Jan 10, 2020
1
18
A team of pharmacists and chemists from the National University of Singapore (NUS) has developed a new anti-cancer drug that has less toxic effects to the kidneys. The new drug works like a "magic bullet" that is delivered ...
Sep 18, 2019
0
5
Treating cancer more selectively and more effectively—this could be achieved with an innovative technology developed by teams of researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the ...
Aug 8, 2019
0
24
The pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that targets toxic substances released by P. gingivalis, a bacteria linked to gum disease.
Jul 18, 2019
0
8
Hesperos Inc., pioneers of the "human-on-a-chip" in vitro system has announced the use of its innovative multi-organ model to successfully measure the concentration and metabolism of two known cardiotoxic small molecules ...
Jul 3, 2019
0
0
Researchers from Duke-NUS Medical School have uncovered a potential mechanism behind cancer suppression in bats that may lead to future therapies for human cancers. The research shows that bat cells accumulate less toxic ...
Jul 2, 2019
0
1146
Researchers at SMU's Center for Drug Discovery, Design and Delivery (CD4) have succeeded in lab testing the use of chemotherapy with a specific protein inhibitor so that the chemotherapeutic is better absorbed by drug-resistant ...
Jun 7, 2019
0
80
Tuberculosis is a potentially deadly though curable disease. Each year about 10 million people develop active cases, and 1.6 million people die. In addition, about 1.7 billion people around the world are infected with TB ...
May 14, 2019
0
74
Little is known about the potential health effects of JUUL e-cigarette products that have recently risen in popularity, especially among adolescents. The Food and Drug Administration, or FDA, has a growing concern about this ...
Apr 9, 2019
0
122
Yale School of Medicine researchers have found that the progression of acute kidney injury to chronic kidney disease (CKD) caused by use of the chemotherapy drug cisplatin is due to unresolved injury and sustained activation ...
Mar 27, 2019
0
1
